| Zabiullah Latif, DO | |
|
1500 Highlands Dr, Medical Education Office, Lititz, PA 17543-7694 | |
| (717) 625-5000 | |
| Not Available |
| Full Name | Zabiullah Latif |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 16 Years |
| Location | 1500 Highlands Dr, Lititz, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639473028 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | OS015983 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lehigh Valley Hospital | Allentown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Professional Anesthesia Services Of North America Pc | 1658698824 | 72 |
News Archive
The Miami-Dade inspector general finds fault with company that used to run Jackson Health System's international marketing program.
A team of 18 researchers at Moffitt Cancer Center in Tampa, Fla., have found that treating high-risk, soft tissue sarcoma patients with a combination of implanted dendritic cells (immune system cells) and fractionated external beam radiation (EBRT) provided more than 50 percent of their trial patients with tumor-specific immune responses lasting from 11 to 42 weeks.
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has begun Phase 1/2a clinical testing with its lead compound, Glymera(PB1023), in patients with Type 2 diabetes.
Scientists at the Immunology Frontier Research Center at Osaka University, Japan have pinpointed a specific molecular events that could explain allergic reactions to air pollution.
› Verified 8 days ago
| Entity Name | Community Anesthesia Associates, Ltd. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245351147 PECOS PAC ID: 0446236160 Enrollment ID: O20040624001407 |
News Archive
The Miami-Dade inspector general finds fault with company that used to run Jackson Health System's international marketing program.
A team of 18 researchers at Moffitt Cancer Center in Tampa, Fla., have found that treating high-risk, soft tissue sarcoma patients with a combination of implanted dendritic cells (immune system cells) and fractionated external beam radiation (EBRT) provided more than 50 percent of their trial patients with tumor-specific immune responses lasting from 11 to 42 weeks.
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has begun Phase 1/2a clinical testing with its lead compound, Glymera(PB1023), in patients with Type 2 diabetes.
Scientists at the Immunology Frontier Research Center at Osaka University, Japan have pinpointed a specific molecular events that could explain allergic reactions to air pollution.
› Verified 8 days ago
| Entity Name | Professional Anesthesia Services Of North America Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972994820 PECOS PAC ID: 1658698824 Enrollment ID: O20150327000075 |
News Archive
The Miami-Dade inspector general finds fault with company that used to run Jackson Health System's international marketing program.
A team of 18 researchers at Moffitt Cancer Center in Tampa, Fla., have found that treating high-risk, soft tissue sarcoma patients with a combination of implanted dendritic cells (immune system cells) and fractionated external beam radiation (EBRT) provided more than 50 percent of their trial patients with tumor-specific immune responses lasting from 11 to 42 weeks.
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has begun Phase 1/2a clinical testing with its lead compound, Glymera(PB1023), in patients with Type 2 diabetes.
Scientists at the Immunology Frontier Research Center at Osaka University, Japan have pinpointed a specific molecular events that could explain allergic reactions to air pollution.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Zabiullah Latif, DO 1500 Highlands Dr, Medical Education Office, Lititz, PA 17543-7694 Ph: (717) 625-5000 | Zabiullah Latif, DO 1500 Highlands Dr, Medical Education Office, Lititz, PA 17543-7694 Ph: (717) 625-5000 |
News Archive
The Miami-Dade inspector general finds fault with company that used to run Jackson Health System's international marketing program.
A team of 18 researchers at Moffitt Cancer Center in Tampa, Fla., have found that treating high-risk, soft tissue sarcoma patients with a combination of implanted dendritic cells (immune system cells) and fractionated external beam radiation (EBRT) provided more than 50 percent of their trial patients with tumor-specific immune responses lasting from 11 to 42 weeks.
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has begun Phase 1/2a clinical testing with its lead compound, Glymera(PB1023), in patients with Type 2 diabetes.
Scientists at the Immunology Frontier Research Center at Osaka University, Japan have pinpointed a specific molecular events that could explain allergic reactions to air pollution.
› Verified 8 days ago
Tyrone D Girdharry, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Highlands Dr, Lititz, PA 17543 Phone: 717-782-3282 Fax: 717-231-8964 | |
Chelsea Cambria, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Highlands Dr, Lititz, PA 17543 Phone: 717-625-5000 | |
Valerie A. Hoffman, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Highlands Dr, Lititz, PA 17543 Phone: 717-625-5000 | |
Charles Adam Whitener, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Highlands Dr, Lititz, PA 17543 Phone: 717-625-5000 | |
Lauren Hammell, Anesthesiology Medicare: Medicare Enrolled Practice Location: 1500 Highlands Dr, Lititz, PA 17543 Phone: 717-625-5668 | |
Jay Paul Mccardell Iv, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Highlands Dr, Lititz, PA 17543 Phone: 717-782-3282 Fax: 717-231-8964 | |
Abigail Walters, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Highlands Dr, Lititz, PA 17543 Phone: 717-625-5000 |